AAAAAA

   
Results: 1-15 |
Results: 15
SR-121787, A NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST
Authors: SAVI P BADORC A LALE A BORDES MF BORNIA J LABOURET C BERNAT A DECOINTET P HOFFMANN P MAFFRAND JP HERBERT JM
Citation: P. Savi et al., SR-121787, A NEW ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST, Thrombosis and haemostasis, 80(3), 1998, pp. 469-476
THE ANTIAGGREGATING AND ANTITHROMBOTIC ACTIVITY OF CLOPIDOGREL IS POTENTIATED BY ASPIRIN IN SEVERAL EXPERIMENTAL-MODELS IN THE RABBIT
Authors: HERBERT JM DOL F BERNAT A FALOTICO R LALE A SAVI P
Citation: Jm. Herbert et al., THE ANTIAGGREGATING AND ANTITHROMBOTIC ACTIVITY OF CLOPIDOGREL IS POTENTIATED BY ASPIRIN IN SEVERAL EXPERIMENTAL-MODELS IN THE RABBIT, Thrombosis and haemostasis, 80(3), 1998, pp. 512-518
IN-VITRO INHIBITION OF HEPARIN-INDUCED PLATELET-AGGREGATION IN PLASMAFROM PATIENTS WITH HIT BY SR-121566, A NEWLY DEVELOPED GP-IIB IIIA ANTAGONIST/
Authors: HERAULT JP LALE A SAVI P PFLIEGER AM HERBERT JM
Citation: Jp. Herault et al., IN-VITRO INHIBITION OF HEPARIN-INDUCED PLATELET-AGGREGATION IN PLASMAFROM PATIENTS WITH HIT BY SR-121566, A NEWLY DEVELOPED GP-IIB IIIA ANTAGONIST/, Blood coagulation & fibrinolysis, 8(3), 1997, pp. 206-207
IN-VITRO INHIBITION OF HEPARIN-INDUCED PLATELET-AGGREGATION IN PLASMAFROM PATIENTS WITH HIT BY SR-121566, A NEWLY DEVELOPED GP IIB IIIA ANTAGONIST/
Authors: HERAULT JP LALE A SAVI P PFLIEGER AM LORMEAU JC HERBERT JM
Citation: Jp. Herault et al., IN-VITRO INHIBITION OF HEPARIN-INDUCED PLATELET-AGGREGATION IN PLASMAFROM PATIENTS WITH HIT BY SR-121566, A NEWLY DEVELOPED GP IIB IIIA ANTAGONIST/, Thrombosis and haemostasis, 1997, pp. 1487-1487
SR-121787 - A POTENT, SYNTHETIC AND ORALLY-ACTIVE PLATELET FIBRINOGENRECEPTOR ANTAGONIST
Authors: SAVI P BADORC A LALE A MAFFRAND JP BERNAT A HOFFMANN P HERBERT JM
Citation: P. Savi et al., SR-121787 - A POTENT, SYNTHETIC AND ORALLY-ACTIVE PLATELET FIBRINOGENRECEPTOR ANTAGONIST, Thrombosis and haemostasis, 1997, pp. 1599-1599
NEW ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR (GPIIB-IIIA) ANTAGONISTS - IDENTIFICATION OF ETHYL THOXYCARBONYL)METHYL]PIPERID-4-YL]AMINO]PROPIONATE (SR-121787) AS A POTENT AND LONG-ACTING ANTITHROMBOTIC AGENT
Authors: BADORC A BORDES MF DECOINTET P SAVI P BERNAT A LALE A PETITOU M MAFFRAND JP HERBERT JM
Citation: A. Badorc et al., NEW ORALLY-ACTIVE NONPEPTIDE FIBRINOGEN RECEPTOR (GPIIB-IIIA) ANTAGONISTS - IDENTIFICATION OF ETHYL THOXYCARBONYL)METHYL]PIPERID-4-YL]AMINO]PROPIONATE (SR-121787) AS A POTENT AND LONG-ACTING ANTITHROMBOTIC AGENT, Journal of medicinal chemistry, 40(21), 1997, pp. 3393-3401
ECHINOMYCIN SUPPRESSES THE PYROGENIC EFFECTS OF ENDOTOXIN AND INTERLEUKIN-1-BETA IN HUMAN ENDOTHELIAL-CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Authors: HERBERT JM LALE A PEREILLO JM DEROCQ JM CASELLAS P
Citation: Jm. Herbert et al., ECHINOMYCIN SUPPRESSES THE PYROGENIC EFFECTS OF ENDOTOXIN AND INTERLEUKIN-1-BETA IN HUMAN ENDOTHELIAL-CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Thrombosis and haemostasis, 75(2), 1996, pp. 359-362
ABILITY OF DIFFERENT FLAVONOIDS TO INHIBIT THE PROCOAGULANT ACTIVITY OF ADHERENT HUMAN MONOCYTES
Authors: LALE A HERBERT JM AUGEREAU JM BILLON M LECONTE M GLEYE J
Citation: A. Lale et al., ABILITY OF DIFFERENT FLAVONOIDS TO INHIBIT THE PROCOAGULANT ACTIVITY OF ADHERENT HUMAN MONOCYTES, Journal of natural products, 59(3), 1996, pp. 273-276
HYPOXIA PRIMES ENDOTOXIN-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES AND ENDOTHELIAL-CELLS BY A PAF-DEPENDENT MECHANISM
Authors: HERBERT JM CORSEAUX D LALE A BERNAT A
Citation: Jm. Herbert et al., HYPOXIA PRIMES ENDOTOXIN-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES AND ENDOTHELIAL-CELLS BY A PAF-DEPENDENT MECHANISM, Journal of cellular physiology, 169(2), 1996, pp. 290-299
AURIN TRICARBOXYLIC-ACID INHIBITS EXPERIMENTAL VENOUS THROMBOSIS
Authors: BERNAT A LALE A HERBERT JM
Citation: A. Bernat et al., AURIN TRICARBOXYLIC-ACID INHIBITS EXPERIMENTAL VENOUS THROMBOSIS, Thrombosis research, 74(6), 1994, pp. 617-627
MALFORMIN-A1 INHIBITS THE BINDING OF INTERLEUKIN-1-BETA (IL1-BETA) AND SUPPRESSES THE EXPRESSION OF TISSUE FACTOR IN HUMAN ENDOTHELIAL-CELLS AND MONOCYTES
Authors: HERBERT JM SAVI P LALE A LAPLACE MC BAUDRY N PEREILLO JM EMONDSALT X
Citation: Jm. Herbert et al., MALFORMIN-A1 INHIBITS THE BINDING OF INTERLEUKIN-1-BETA (IL1-BETA) AND SUPPRESSES THE EXPRESSION OF TISSUE FACTOR IN HUMAN ENDOTHELIAL-CELLS AND MONOCYTES, Biochemical pharmacology, 48(6), 1994, pp. 1211-1217
POLYUNSATURATED FATTY-ACIDS REDUCE PYROGEN-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
Authors: LALE A HERBERT JM
Citation: A. Lale et Jm. Herbert, POLYUNSATURATED FATTY-ACIDS REDUCE PYROGEN-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES, Biochemical pharmacology, 48(2), 1994, pp. 429-431
BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-27388, A DUAL ANTIOXIDANT AND PAF RECEPTOR ANTAGONIST
Authors: HERBERT JM FRAISSE L BACHY A VALETTE G SAVI P LAPLACE MC LASSALLE J ROCHE B LALE A KEANE PE MAFFRAND JP
Citation: Jm. Herbert et al., BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF SR-27388, A DUAL ANTIOXIDANT AND PAF RECEPTOR ANTAGONIST, Journal of lipid mediators, 8(1), 1993, pp. 31-51
MALFORMIN-A1, A POTENT IL-1-RECEPTOR ANTAGONIST, INHIBITS PYROGEN-INDUCED EXPRESSION OF TISSUE FACTOR IN HUMAN ENDOTHELIAL-CELLS AND MONOCYTES
Authors: HERBERT JM SAVI P LALE A LAPLACE MC BAUDRY N EMONDSALT X
Citation: Jm. Herbert et al., MALFORMIN-A1, A POTENT IL-1-RECEPTOR ANTAGONIST, INHIBITS PYROGEN-INDUCED EXPRESSION OF TISSUE FACTOR IN HUMAN ENDOTHELIAL-CELLS AND MONOCYTES, Thrombosis and haemostasis, 69(6), 1993, pp. 740-740
IL-4 AND IL-13 EXHIBIT COMPARABLE ABILITIES TO REDUCE PYROGEN-INDUCEDEXPRESSION OF PROCOAGULANT ACTIVITY IN ENDOTHELIAL-CELLS AND MONOCYTES
Authors: HERBERT JM SAVI P LAPLACE MC LALE A DOL F DUMAS A LABIT C MINTY A
Citation: Jm. Herbert et al., IL-4 AND IL-13 EXHIBIT COMPARABLE ABILITIES TO REDUCE PYROGEN-INDUCEDEXPRESSION OF PROCOAGULANT ACTIVITY IN ENDOTHELIAL-CELLS AND MONOCYTES, FEBS letters, 328(3), 1993, pp. 268-270
Risultati: 1-15 |